Breast Cancer Clinical Trial
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Summary
The main purpose of this study is to compare progression free survival in patients treated with AZD8931 given in combination with anastrozole versus anastrozole alone. The secondary objective is to investigate the safety and tolerability of AZD8931 given in combination with anastrozole.
Eligibility Criteria
Inclusion Criteria:
Patients that have locally advanced or metastatic breast cancer. Lesions should not be amenable to surgery or radiation of curative intent
Hormone therapy-naive
Estimated life expectancy of more than 12 weeks
Exclusion Criteria:
Last dose of prior anti-cancer therapy received within 14 days (or longer if required)
Any eye injury or corneal surgery within 3 months prior to receiving first dose of study drug.
Currently receiving (and unwilling to discontinue) oestrogen replacement therapy. (last dose <7 days prior to randomisation)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Lake Success New York, , United States
Belo Horizonte , , Brazil
Goiânia , , Brazil
Ijuà , , Brazil
Porto Alegre , , Brazil
Rio de Janeiro , , Brazil
Sao Paulo , , Brazil
São Paulo , , Brazil
Vancouver British Columbia, , Canada
Ottawa Ontario, , Canada
Montreal Quebec, , Canada
Brno , , Czech Republic
Olomouc , , Czech Republic
Praha 2 , , Czech Republic
Praha 4 , , Czech Republic
Helsinki , , Finland
Tampere , , Finland
Turku , , Finland
Bangalore , , India
Hyderabad , , India
Mumbai , , India
Pune , , India
Trivandrum , , India
Vellore , , India
Niigata-shi , , Japan
Osaka-shi , , Japan
Ota-shi , , Japan
Sapporo-shi , , Japan
Seoul , , Korea, Republic of
Durango , , Mexico
Juchitan , , Mexico
Merida , , Mexico
Monterrey , , Mexico
Callao , , Peru
Lima , , Peru
Piura , , Peru
Iloilo City , , Philippines
Lipa City , , Philippines
Pasay City , , Philippines
Quezon City , , Philippines
Białystok , , Poland
ElblÄ…g , , Poland
Kraków , , Poland
Warszawa , , Poland
Kuzmolovsky , , Russian Federation
Moscow , , Russian Federation
Saint Petersburg , , Russian Federation
Durban , , South Africa
Pretoria , , South Africa
Taipei , , Taiwan
Bangkok , , Thailand
Songkla , , Thailand
Dnipropetrovsk , , Ukraine
Lviv , , Ukraine
Birmingham , , United Kingdom
Bournemouth , , United Kingdom
Coventry , , United Kingdom
Leicester , , United Kingdom
London , , United Kingdom
Nottingham , , United Kingdom
Surrey , , United Kingdom
Wythenshawe, Manchester , , United Kingdom
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.